Genetic polymorphisms of glutathione S-transferases and disease activity of rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 27, Issue 2, 2009, Pages 229-236

  Grabar, P Bohanec ^a   Logar, D ^b   Tomsic M ^b   Rozman, B ^b   Dolzan V ^a,c  

^a Faculty of Medicine   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Disease activity; OST polymorphism; Rheumatoid arthritis; Smoking

Indexed keywords

ADALIMUMAB; ALANINE; AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETANERCEPT; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; GOLD; INFLIXIMAB; ISOLEUCINE; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SALAZOSULFAPYRIDINE; TACROLIMUS; VALINE;

ADULT; AGED; CONFERENCE PAPER; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ENZYME ACTIVITY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE INTERACTION; GENOTYPE; HIGH RISK PATIENT; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLITE; MONOTHERAPY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TREATMENT WITHDRAWAL;

AGED; ARTHRITIS, RHEUMATOID; FEMALE; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 67249147855     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (46)

1. HAYES JD, FLANAGAN JU, JOWSEY IR: Glutathione transferases. Annu Rev Pharmacot Toxicot 2005; 45: 5 1-88.
2. WIDERSTEN M, PEARSON WR, ENGSTROM A. MANNERVIK B: Heterologous expression of the allelic variant mu-class glutathione transferases mu and psi. Biochem J 1991; 276 (Pt 2): 5 19-24.
3. SEIDEGARD J, VORACHEK WR, PERO RW. PEARSON WR: Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Nati Acad Sci USA 1988; 85: 7293-7.
4. MCLELLAN RA. OSCARSON M, ALEXANDRIE AK et at.: Characterization of a human glutathione S-transferase mu cluster containing a duplicated GSTMI gene that causes ultrarapid enzyme activity. Mot Pharmacot 1997; 52: 958-65.
5. PEMBLE S, SCHROEDER KR, SPENCER SR et at.: Human glutathione S-transferase theta (GSTT1): eDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994; 300 (Pt 1): 271-6.
6. ALI-OSMAN F, AKANDE O, ANTOUN G. MAO JX. BUOLAMWINI J: Molecular cloning, characterization, and expression in Escherichia coh of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biot Chem 1997; 272: 10004-12.
7. WATSON MA, STEWART RK, SMITH GB, MASSEY TB, BELL DA: Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and popu lation frequency distribution. Carcinogenesis 1998; 19: 275-80.
8. ZHONG SL, ZHOU SF, CHEN X et at.: Relationship between genotype and enzyme activity of glutathione S-transferases Ml and P1 in Chinese. Eur J Pharm Sci 2006; 28: 77-85.
9. MATTEY DL, HASSELL AB, PLANT M et at.: Association of polymorphism in glutathione S-transferase loci with susceptibility and outcome in rheumatoid arthritis: comparison with the shared epitope. Ann Rheum Dis 1999; 58: 164-8.
10. MORINOBU S, MORINOBU A, KANAGAWA S. HAYASHI N, NISHIMURAK, KUMAGAI S: Glutathione S-transferase gene polymorphisms in Japanese patients with rheumatoid arthritis. Ctin Exp Rheumatol 2006; 24: 268-73.
11. YUN BR, EL-SOHEMY A, CORNELIS MC, BAE SC: Glutathione S-transferase Ml, TI, and P1 genotypes and rheumatoid arthritis. J Rheumatot 2005; 32: 992-7.
12. BEKRIS LM, SHEPHARD C, PETERSON M et at.: Glutathione-s- transferase Ml and TI polymorphisms and associations with type I diabetes age-at-onset. Autoimmunity 2005; 38: 567-75.
13. TAMER L, CALIKOGLU M, ATES NA et at.: Glutathione-S-transferase gene polymorphisms (GSTT1, GSTMI, GSTP1) as increased risk factors for asthma. Respirotogy 2004; 9: 493-8.
14. LAI KC. CHEN WC, TSAI FJ. LI SY, CHOU MC, JENG LB: Glutathione S-transferase Ml gene null genotype and gastric cancer risk in Taiwan. Hepatogastroenterotogv 2005; 52: 1916-9.
15. ATES NA, TAMER L. ATES C et at.: Glutathione S-transferase Ml, Tl, P1 genotypes and risk for development of colorectal cancer. Biochern Genet 2005; 43: 149-63.
16. DIRKSEN U, MOGHADAM KA, MAMBETOVA C, ESSER C, FUHRER M, BURDACH S: Glutathione S transferase theta I gene (GSTT1) null genotype is associated with an increased risk for acquired aplastic anemia in children. Pediatr Res 2004; 55: 466-71.
17. ERTUNC D, ABAN M, TOK BC, TAMER L. ARSLAN M, DILEK 5: Glutathione-S-transferase P1 gene polymorphism and susceptibility to endometriosis. Hum Reprod 2005; 20: 2157-61.
18. LAI R, CREVIER L, THABANE L: Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a metaanalysis. Cancer Epidetniol Biomarkers Prey 2005; 14: 1784-90.
19. LOFF S, SVOBODA P. KASAI H et at.: Prospective study of urinary excretion of 7- methylguanine and the risk of lung cancer: Effect modification by mu class glutathione-S-transferases. Int J Cancer 2007; 121: 1579-84.
20. SALAGOVIC I, KALINA I, STUBNA J et at.: Genetic polymorphism of glutathione 5- transferases MI and Ti as a risk factor in lung and bladder cancers. Neoptasma 1998; 45: 312-7.
21. SRI VASTAVA DS, MISHRA DK, MANDHANI A, MITAL B, KUMAR A, MITTAL RD: Association of genetic polymorphism of glutathione S-transferase Ml, Ti, P1 and susceptibility to bladder cancer. Eur Urot 2005; 48: 339-44.
22. NAZAR-STEWART V. VAUGHAN TL, STAPLETON P. VAN LOO J, NICOL-BLADES B, EATON DL: A population-based study of giutathione S-transferase Mi, TI and P1 genotypes and risk for lung cancer. Lung Cancer 2003; 40: 247-5 8.
23. CRIS WELL LA, SAAG KG, MIKULS TR et at.: Smoking interacts with genetic risk factors in the development of rheumatoid arthritis among older Caucasian women. Ann Rheum Dis 2006; 65: 1163-7.
24. KARLSON EW, LEE IM, COOK NR, MANSON JE. BURING JE, HENNEKENS CH: A retrospective cohort study of cigarette smoking and risk of rheumatoid arthritis in female health professionals. Arthritis Rheum 1999; 42: 910-7.
25. SAAG KG. CERHAN JR. KOLLURI S. OHASHI K, HUNNINGHAKE GW, SCHWARTZ DA: Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis 1997; 56: 463-9.
26. MANFREDSDOTTIR VF, VIKINGSDOTTIR T. JONSSON T et at.: The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology (Oxford) 2006; 45: 734-40.
27. MATTEY DL, HUTCHINSON D. DAWES PT et at.: Smoking and disease severity in rheumatoid arthritis: association with polymorphism at the glutathione S-transferase Ml locus. Arthritis Rheum 2002; 46: 640-6.
28. ARNETT FC, EDWORTI-IY SM, BLOCH DA et at.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
29. FELSON DT, ANDERSON JJ, BOERS M et at.: The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum 1993; 36: 729-40.
30. PREVOO ML. VAN 'T HOF MA, KUPER HH, VAN LEEUWEN MA, VAN DE PUTTE LB. VAN RIEL PL: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
31. VAN RIEL PL. VAN GESTEL AM: Clinical outcome measures in rheumatoid arthritis. Ann Rheum Dis 2000; 59 (Suppl. 1): i28-31.
32. MAKINEN H, KAUTIAINEN H, HANNONEN P, SOKKA T: Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? Ann Rheum Dis 2005; 64: 1410-3.
33. BRUCE B, FRIES JF: The Stanford Health Assessment Questionnaire: Dimensions and Practical Applications. Heatth Quat Life Outcomes 2003; 1: 20.
34. FRIES JF, SPITZ P. KRAINES RG, HOLMAN HR: Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-45.
35. AUPPERLE KR, ALSALAMEH 5, STOCK KP, BURMESTER GR, KALDEN JR: [Comparison of rheumatoid test procedures--value and critical interpretation of sensitivity and specificity and their effect on pre-test and post-test probabilityJ. ZRheumatol 1996; 55: 158-67.
36. MILLER SA, DYKES OD, POLESKY HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
37. CHEN CL, LIU Q. RELLING MV: Simultaneous characterization of glutathione S-transferase Ml and TI polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics 1996; 6: 187-91.
38. DOLZAN V, RUDOLF Z, BRESKVAR K: Genetic susceptibility to environmental carcinogenesis in Slovenian melanoma patients. Acta Dermatoven APA 2006; 15: 69-78.
39. GARTE S. GASPARI L, ALEXANDRIE AK et at.: Metabolic gene polymorphism frequencies in control populations. Cancer Epide miolBiomarkers Prey 2001; 10: 1239-48.
40. TURESSON C. MATESON EL: Genetics of rheumatoid arthritis. Mayo Clin Proc 2006; 81: 94-101.
41. OLIVER JE, WORTHINGTON J. SILMAN AJ: Genetic epidemiology of rheumatoid arthritis. Curr Opin Rheumatot 2006; 18: 141-6.
42. MATTEY DL. HASSELL AB, DAWES PT et at.: Influence of polymorphism in the manganese superoxide dismutase locus on disease outcome in rheumatoid arthritis: evidence for interaction with glutathione S-transferase genes. Arthritis Rheum 2000: 43: 859-64.
43. VIDAN-JERAS B. JURCA B. DOLZAN V. JERAS M, BRESKVAR K, BOHINJEC M: Caucasian Slovenian normal, in GJERTSON D, TERASAKI P (Eds.): HLA 1998. Lenexa, American societe for histocompatibititv and immunogenetics 1998: 180-1.
44. th international histocompatibility workshop and conference. Paris, EDK. Medical and scientific international publisher 1997: 307-13.
45. LANDI S: Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000: 463: 247-83.
46. HAYES JD. STRANGE RC: Glutathione S- transferase polymorphisms and their biological consequences. Pharmacology 2000: 61: 154-66.